No black box warning on record for Continuous Correction Cream
As of the latest FDA labeling reviewed, Continuous Correction Cream (HOMOSALATE 10% OCTISALATE 4.9% OCTOCRYLENE 4%) does not carry a black box warning. Standard warnings and precautions still apply — see the full Continuous Correction Cream medicine page for the complete safety profile.